Stem Cell Therapeutics Corp. (SCT) announced it has received a No Objection Letter (NOL) from Health Canada for the company supported, investigator-led phase IIa, single centre, open label study to characterize the safety of human Chorionic Gonadotropin (hCG) & Erythropoietin (EPO) in severe traumatic brain injury (TBI) patients .
Patients transplanted with peripheral blood stem cells (PBSC) have no difference in survival compared with patients given bone marrow after 10 years, according to the largest randomised study comparing the effect of type of transplant on survival, published Online First in The Lancet Oncology.
… come from donors’ bone marrow or from peripheral blood. It has been unclear whether long-term outcomes differ depending on the source of these stem cells. Ten-year survival rates after allogeneic stem-cell transplant in leukemia patients were …
The MS Society has called for researchers and scientists to come forward with research projects investigating the potential benefit of stem cells in multiple sclerosis (MS). A new partnership between the MS Society and the UK Stem Cell Foundation has levered £1million to be specifically ring-fenced for translational, pre-clinical and clinical trials…
Until his recent heart attack, David Kenney of East Moriches was running six miles daily. Now he’s a pioneering patient in a clinical study that will determine whether 100 million stem cells infused into his body can fix his ailing heart. Doctors at …
… focused on cells that transmit information from the brain’s cortex, some of which are responsible for muscle control. It is these neurons that are lost or damaged in spinal cord injuries and amyotrophic lateral sclerosis (ALS). “These stem cell …
Stem cells are one of the most exciting areas of modern research. Their unique characteristics mean that scientists can use them to create any type of human cell in vitro. Embryonic stem cells are also key tools for future studies on diseases like …
Further appeal is expected after a court overturned a Lenawee County jury’s decision to order an insurance company to pay for a treatment in Portugal that helped a paralyzed man recover some control of his lower body. “It’s fairly frustrating …
Linheng Li, Ph.D., Investigator, together with Hans Clevers, M.D., Ph.D., Director of the Hubrecht Institute in Utrecht, Netherlands, co-authored a prospective review published today by the journal Science that proposes a model of mammalian adult …
Proton Laboratories, Inc., through the newly acquired Regenobody S.A, said Jan. 12 it has obtained a license, through LifeXtension Worldwide, from the Government for harvesting, incubating, and transplanting stems cells. Proton President Armando …